Union Minister of Science and Technology, Dr Jitendra Singh, stated on December 12 that India is betting on generative AI to reshape drug discovery. Speaking about technologies like PathGennie, he highlighted how India's open-source push and computational biology capabilities are positioning the country as a leader in affordable pharmaceutical innovation. India's pharmaceutical sector, valued at over USD 50 billion, stands to benefit from AI-driven approaches that could reduce drug development timelines from the typical 10-12 years. The government is investing in computational infrastructure at national research labs to support these efforts.
Union Minister Jitendra Singh Says India Bets on Generative AI for Drug Discovery
AQuick answer
India leveraging generative AI for drug discovery; PathGennie part of open-source push in computational biology.
Key facts
- Union Minister Dr Jitendra Singh stated India is betting on generative AI to reshape drug discovery
- PathGennie highlighted as a key technology in India's computational biology and open-source AI push
- India's pharmaceutical sector valued at over USD 50 billion
- AI-driven approaches could reduce drug development timelines from the typical 10-12 years
- Government investing in computational infrastructure at national research labs to support pharmaceutical innovation
Mains angle
Q: Examine the role of generative AI in transforming pharmaceutical drug discovery in India and the government's open-source initiatives in computational biology.
Answer (50 words):
Union Science Minister Dr Jitendra Singh stated on December 12 that India is betting on generative AI to reshape drug discovery, citing tools like PathGennie. India's open-source push and computational biology capabilities position the country as a leader in affordable pharmaceutical innovation. The pharma sector valued over $50 billion benefits significantly.
Static prep for this topic
Read the permanent syllabus behind this story.
Recent Advancements & Indian ContributionsScience & TechnologyGenetics, Biotechnology & NanotechnologyScience & Technology
6-axis classification
CoverageNationalSubjectScience & TechnologyExamBasic Computer Instructor · CET Graduation · CET Senior Secondary · EO/RO · LDC · Mahila Supervisor · Patwar · PTI · RAS · REET · RPSC SI · School Lecturer · Senior Computer Instructor · Senior Teacher · UPSC · Vanpal · BothSourceANI
Appears in these topics
Practice MCQ from this story
SolveTap an option below. Correct or incorrect feedback appears instantly.
Linked questionMedium
India's bioeconomy reached what value in 2025 according to the IBER 2026 report?
Explanation · Correct answer B
India's bioeconomy reached $195.3 billion in 2025 with 18% growth, contributing 4.8% to GDP, as per IBER 2026.
Source: ANI
Frequently asked questions
What did Dr Jitendra Singh say about generative AI and drug discovery?
Union Minister of Science and Technology Dr Jitendra Singh stated on December 12 that India is betting on generative AI to reshape drug discovery.
How did he connect PathGennie with India's affordable pharmaceutical innovation push?
Speaking about technologies like PathGennie, he highlighted how India's open-source push and computational biology capabilities are positioning the country as a leader in affordable pharmaceutical innovation.
What sector value and development timeline are linked to AI-driven drug discovery?
India's pharmaceutical sector is valued at over USD 50 billion. AI-driven approaches could reduce drug development timelines from the typical 10-12 years.
What government investment is supporting the generative AI drug-discovery effort?
The government is investing in computational infrastructure at national research labs to support these efforts.
Was this useful?
Share corrections or missing exam angles with the editorial team.
Send feedback